Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health (NYSE: CVS) has scheduled its third quarter 2025 earnings conference call for Wednesday, October 29th, 2025, at 8:00 a.m. ET. During this call, the company will discuss its Q3 2025 financial performance with analysts and investors.
The event will be accessible through an audio webcast on the Investor Relations section of CVS Health's website at investors.cvshealth.com. The webcast recording will remain available for replay on the website for one year following the event.
Omnicare, a subsidiary of CVS Health (NYSE: CVS), has initiated voluntary Chapter 11 bankruptcy proceedings in response to litigation challenges and industry-wide financial pressures. The company has secured $110 million in debtor-in-possession financing to maintain operations during the restructuring process.
The bankruptcy filing follows a court ruling in the U.S. District Court for the Southern District of New York regarding alleged technical violations of pharmacy law. Omnicare plans to use this process to evaluate restructuring options, including a potential standalone restructuring or sale strategy. The company emphasizes that it will continue providing uninterrupted pharmacy services to long-term care facilities and maintain regular business operations, including employee wages and vendor payments.
CVS Health's Aetna (NYSE: CVS) announced the expansion of its Aetna Clinical Collaboration (ACC) program, which will be implemented in ten hospitals by the end of 2025. The program embeds Aetna nurses within hospital staff to support Medicare Advantage members during their hospital discharge and transition process.
The initiative, which has already shown promising results with 25% of program members actively engaged with an Aetna care manager, aims to reduce 30-day readmission rates and hospital length of stay by 5% year-over-year. The program is particularly significant as nearly 20% of Medicare-insured patients face hospital readmission within 30 days of discharge.
CVS Health (NYSE: CVS) has reopened its Pacific Palisades store at 864 Swarthmore Avenue, which was damaged during the January wildfires in California. The store is one of the first businesses to resume operations in the area, featuring an expanded pharmacy, improved consultation areas, and updated layout.
The renovated location has been tailored to serve current community needs, particularly focusing on construction workers and first responders, with an expanded selection of grab-and-go items. CVS Health has demonstrated its commitment to wildfire recovery efforts through $2 million in grants and product donations to affected California communities.
CVS Health (NYSE: CVS) has declared a quarterly dividend of $0.665 per share on its Common Stock. The dividend will be paid on November 3, 2025, to shareholders of record as of October 23, 2025. This regular dividend announcement demonstrates CVS Health's continued commitment to providing shareholder returns.
CVS Health (NYSE: CVS) Foundation has announced a $1 million grant distribution through its Hometown Fund to support 20 Rhode Island-based organizations. The initiative aims to improve healthcare accessibility and community health outcomes in areas surrounding CVS's corporate offices.
The grants will support various community services including nutritious food access, supportive housing, and educational resources. Since 2022, the CVS Health Foundation has invested $8 million in Greater Hartford and Rhode Island organizations. Notable recipients include Connecting for Children and Families, Adoption Rhode Island, and Amos House, among others.
This initiative complements CVS Health's broader community engagement efforts, including their Project Health initiative which screened over 1,300 Rhode Island participants last year, and a previous $1 million grant to Women & Infants Hospital for maternal health services.
CVS Health Foundation (NYSE: CVS) has announced a $1 million grant distribution through its Hometown Fund to support 20 organizations in the Greater Hartford area. The grants, focused on improving healthcare accessibility and community health outcomes, will support various services including nutritious food, supportive housing, and educational resources.
Malta House of Care, Inc. is among the key beneficiaries, receiving funds to provide free behavioral health care and community support. Since 2022, the Foundation has invested $8 million in Greater Hartford and Rhode Island organizations. Additionally, CVS Health has invested $2 million in creating a Hartford Health Zone and $16 million in affordable housing initiatives in the area.
CVS Health (NYSE: CVS) has announced the availability of updated 2025-2026 flu vaccines at CVS Pharmacy and MinuteClinic locations nationwide. A company survey reveals 63% of consumers plan to get flu shots this season, with 65% planning to get vaccinated before November.
The company is expanding its healthcare services by offering 3-in-1 combo testing for Influenza A, Influenza B, and COVID-19 in 38 states and D.C. In select states, pharmacists can both test and treat these conditions in a single visit. CVS is incentivizing vaccinations with a $10 off $20 purchase offer and $2 ExtraBucks Rewards for ExtraCare members receiving CDC-recommended vaccines.
CVS Health (NYSE:CVS) reported Q2 2025 results with total revenues of $98.9 billion, up 8.4% year-over-year. The company's GAAP diluted EPS decreased to $0.80 from $1.41, while Adjusted EPS was $1.81. CVS generated year-to-date cash flow from operations of $6.5 billion.
Key developments include CVS Pharmacy's agreement to acquire certain Rite Aid prescription files and stores across multiple states, and the company's $20 billion commitment over the next decade to simplify the U.S. health system. The company updated its 2025 guidance, revising GAAP EPS down to $3.84-$3.94 but raising Adjusted EPS to $6.30-$6.40 and cash flow guidance to at least $7.5 billion.
Performance varied across segments, with Health Care Benefits showing strong growth, Pharmacy & Consumer Wellness improving, while Health Services experienced a decline. The company recorded $833 million in litigation charges related to past business practices.
[ "Total revenues increased 8.4% to $98.9 billion across all segments", "Health Care Benefits segment adjusted operating income up 39.4% to $1.3 billion", "Pharmacy & Consumer Wellness segment adjusted operating income increased 7.6% to $1.3 billion", "Same store prescription volume grew 6.4% on a 30-day equivalent basis", "Raised full-year 2025 Adjusted EPS guidance to $6.30-$6.40 from $6.00-$6.20", "Increased cash flow from operations guidance to at least $7.5 billion from $7.0 billion", "Strategic expansion through Rite Aid prescription files and store acquisitions" ]Aetna, a CVS Health company (NYSE: CVS), has unveiled significant digital healthcare innovations including Aetna Care Paths and AI-driven programs. The initiative is part of CVS Health's $20 billion multi-year digital investment to simplify healthcare navigation.
The new Aetna Health app features include personalized care recommendations, vaccine scheduling, improved claims visualization, and AI-powered chat support. Notably, AI-driven clinical solutions provide nurses with 90 additional minutes daily for member interactions. The platform also introduces Smart Compare for provider recommendations and enhanced accessibility features.
Key innovations include provider availability verification through claims data, personalized cost tracking, and AI-powered bill matching for claims submission, representing a shift from transactional to journey-based healthcare management.